日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Brace Forms Alliance with Aso, Gains New Investments
Brace Inc., which provides the orthodontic treatment online support service "SMILE ACCESS…
MediciNova Shares Update on ALS, Triglyceride Trials
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and…
Curadh, Alpha Fusion Advance Astatine-211 Collaboration
Curadh MTR Inc. and Alpha Fusion, Inc. are set to showcase their…
Alloy Therapeutics, KSAC team up to grow Japan Biotechs
Alloy Therapeutics Co. Ltd. (Alloy Japan) signed a Memorandum of Understanding (MOU)…
COSMOS taps RELEX to optimize supply chain and growth
COSMOS Pharmaceutical Corporation, one of Japan’s largest drugstore chains, has chosen RELEX…
SCOP Smart Care Platform Obtains TAIS Code Approval
Zenko Research Institute Co., Ltd. is pleased to announce that the smart…
TXP Medical and Malaysia’s MHNexus launch partnership
TXP Medical Co., Ltd. is pleased to announce that it has entered…
IBM Japan Launches AI to Support Hospital Operations
IBM Japan has launched a new "Hospital Operations Support AI Solution" aimed…
Latest Article
English